Your browser doesn't support javascript.
loading
Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis.
Davey, Matthew G; Cleere, Eoin F; O'Donnell, John P; Gaisor, Sara; Lowery, Aoife J; Kerin, Michael J.
Affiliation
  • Davey MG; Department of Surgery, The Lambe Institute for Translational Research, National University of Ireland, Galway, Galway, H91 YR71, Republic of Ireland. m.davey7@nuigalway.ie.
  • Cleere EF; Department of Surgery, The Lambe Institute for Translational Research, National University of Ireland, Galway, Galway, H91 YR71, Republic of Ireland.
  • O'Donnell JP; Department of Surgery, The Lambe Institute for Translational Research, National University of Ireland, Galway, Galway, H91 YR71, Republic of Ireland.
  • Gaisor S; Department of Surgery, The Lambe Institute for Translational Research, National University of Ireland, Galway, Galway, H91 YR71, Republic of Ireland.
  • Lowery AJ; Department of Surgery, The Lambe Institute for Translational Research, National University of Ireland, Galway, Galway, H91 YR71, Republic of Ireland.
  • Kerin MJ; Department of Surgery, The Lambe Institute for Translational Research, National University of Ireland, Galway, Galway, H91 YR71, Republic of Ireland.
Breast Cancer Res Treat ; 193(3): 535-544, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35426541
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2022 Type: Article